These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36970592)

  • 1. Systemic treatment for metastatic colorectal cancer.
    Leowattana W; Leowattana P; Leowattana T
    World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
    Atreya CE; Yaeger R; Chu E
    Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of metastatic colorectal cancer in the era of precision medicine.
    Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
    CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status and prospect of immunotherapy in colorectal cancer.
    Shu Y; Zheng S
    Clin Transl Oncol; 2024 Jan; 26(1):39-51. PubMed ID: 37301804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
    Taieb J; Jung A; Sartore-Bianchi A; Peeters M; Seligmann J; Zaanan A; Burdon P; Montagut C; Laurent-Puig P
    Drugs; 2019 Sep; 79(13):1375-1394. PubMed ID: 31347092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer.
    Underwood PW; Ruff SM; Pawlik TM
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic landscape of treatment refractory metastatic colorectal cancer.
    Eefsen RL; Simonsen KS; Grundtvig P; Klarskov L; Chen IM; Høgdall D; Jensen BV; Lorentzen T; Poulsen TS; Theile S; Nielsen D; Høgdall E
    Acta Oncol; 2021 Dec; 60(12):1621-1628. PubMed ID: 34606390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
    Lonardi S; Nimeiri H; Xu C; Zollinger DR; Madison RW; Fine AD; Gjoerup O; Rasola C; Angerilli V; Sharma S; Wu HT; Palsuledesai CC; Malhotra M; Aleshin A; Loupakis F; Renkonen E; Hegde P; Fassan M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring immunotherapy in colorectal cancer.
    Weng J; Li S; Zhu Z; Liu Q; Zhang R; Yang Y; Li X
    J Hematol Oncol; 2022 Jul; 15(1):95. PubMed ID: 35842707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments.
    Tang YL; Li DD; Duan JY; Sheng LM; Wang X
    World J Gastroenterol; 2023 Feb; 29(6):926-948. PubMed ID: 36844139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
    Maurel J; Postigo A
    Curr Cancer Drug Targets; 2015; 15(8):703-15. PubMed ID: 26452385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
    Van Cutsem E; Cervantes A; Adam R; Sobrero A; Van Krieken JH; Aderka D; Aranda Aguilar E; Bardelli A; Benson A; Bodoky G; Ciardiello F; D'Hoore A; Diaz-Rubio E; Douillard JY; Ducreux M; Falcone A; Grothey A; Gruenberger T; Haustermans K; Heinemann V; Hoff P; Köhne CH; Labianca R; Laurent-Puig P; Ma B; Maughan T; Muro K; Normanno N; Österlund P; Oyen WJ; Papamichael D; Pentheroudakis G; Pfeiffer P; Price TJ; Punt C; Ricke J; Roth A; Salazar R; Scheithauer W; Schmoll HJ; Tabernero J; Taïeb J; Tejpar S; Wasan H; Yoshino T; Zaanan A; Arnold D
    Ann Oncol; 2016 Aug; 27(8):1386-422. PubMed ID: 27380959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
    Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
    Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database.
    Nakamura Y; Olsen S; Zhang N; Liao J; Yoshino T
    Curr Oncol; 2022 May; 29(5):3433-3448. PubMed ID: 35621667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future targets and therapies in metastatic colorectal cancer.
    Dzunic M; Petkovic I; Cvetanovic A; Vrbic S; Pejcic I
    J BUON; 2019; 24(5):1785-1792. PubMed ID: 31786838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment sequencing in metastatic colorectal cancer.
    Modest DP; Pant S; Sartore-Bianchi A
    Eur J Cancer; 2019 Mar; 109():70-83. PubMed ID: 30690295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development.
    Gmeiner WH
    Onco Targets Ther; 2021; 14():2121-2130. PubMed ID: 33790575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.